Despite many successes in 2023, the biotechnology industry saw a year-on-year decline in market capitalisation for the first time since 2012, according to GEN’s A-list. The largest biotech companies closed the year with a total market cap of $1.711 trillion, down 2.2% from the previous year. The decline reflects falling vaccine sales, increasing financial insecurity, and upcoming patent expiration for several major drugs.
Dashboards, automation on top of palliative care nurses’ wishlist
Aged care nurses in Australia have voiced their interest in improved and integrated technology solutions to provide streamlined end-of-life care, though they face challenges with
